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Abstract: Background: The aim of is to determine the association of vitamins with glaucoma by
performing a systematic review and meta-analyses. Methods: Studies on the relation of vitamins
and glaucoma published up to December 2017 were identified in the PubMed and Embase
database. Data on vitamins (method of assessment), glaucoma (type and method of assessment),
study characteristics and quality were recorded. In case of multiple studies for one nutrient a
meta-analysis was performed. Results: A total of 629 articles were identified of which 36 were
included in the systematic review. The meta-analysis included five of them (940 open-angle glaucoma
(OAG) cases and 123,697 controls in total) and resulted in an odds ratio [95% confidence interval]
(OR [95% CI]) of 0.58 [0.37–0.91] for dietary vitamin A, though heterogeneity was high (I2 = 51%).
After omitting studies that contributed significantly to the heterogeneity, the pooled OR [95% CI]
was 0.45 [0.30–0.68] for dietary vitamin A on OAG (I2 = 0%). For vitamin B1, C and E no significant
association with OAG was found (OR [95% CI]: 0.84 [0.47–1.51]; 0.68 [0.38–1.22]; 0.95 [0.75–1.19];
respectively). However, after addressing heterogeneity, vitamin C showed a protective effect as
well. Especially, foods high in these vitamins (e.g., dark green vegetables) were protective for
OAG. Conclusions: Dietary intake of vitamin A and C showed a beneficial association with OAG;
however, findings on blood levels of vitamins do not show a clear relation with OAG.
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1. Introduction
Exposure to nutrients is ubiquitous. Without it, we generally cannot survive and an exposure too
high or too low causes health problems. Vitamins are a good example and the ubiquitous exposure to
vitamins has led to many epidemiological studies for many diseases. Glaucoma is no exception [1].
The need to study the occurrence of glaucoma in relation to vitamins stems from the observation
that glaucoma is the leading cause of irreversible blindness, that almost half of the glaucoma cases
are undiagnosed, and that the prevalence is increasing over time [2,3]. This makes it relevant to
investigate whether vitamins have a preventive effect on the occurrence of glaucoma i.e., may be
used as a preventive measure. Several studies suggested that nutrition might have an effect on
the intraocular pressure (IOP; the only treatable risk factor of glaucoma) or glaucoma, mediated by
oxidative stress. Oxidative stress occurs when more reactive oxygen species are formed then the
anti-oxidative capacity of the cell can handle. This leads to damage of the aqueous humour outflow
system of the eye, the trabecular meshwork, resulting in an increase in IOP and eventually loss of
retinal ganglion cells [4–6]. Moreover, a low ocular (in the aqueous humour) or systemic anti-oxidative
capacity is associated with more severe glaucomatous visual field loss [5,7,8]. Although several studies
have been conducted on the association of vitamins with glaucoma, it is often noticed that the results
are conflicting leaving physicians and patients in doubt about the effect of vitamins on glaucoma.
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To address the conflicting results of the association of vitamins with glaucoma, we performed
a systematic review and meta-analyses to summarize the evidence. In this review, we assess the
quality of the studies, calculate the pooled effect size and explain the heterogeneity between studies.
Finally we report the level of evidence of a protective effect of vitamins on the occurrence of glaucoma.
2. Methods
The systematic review was performed according to the reporting guidelines implied by the
Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) and Meta-analysis Of
Observational Studies in Epidemiology (MOOSE) [9,10].
2.1. Search Strategy and Study Eligibility
We conducted a PubMed and Embase database search for articles published prior to 1 December 2017.
The search term used in PubMed included (“vitamin (All Fields) AND glaucoma (All Fields)”).
The included entries had to have an available abstract, which had to be either in English or German.
Furthermore, investigations had to be performed in humans (or human tissue) and not in animals.
Titles and abstracts were scanned to select eligible articles in which the relation between vitamins
and glaucoma was studied without any restricting selection criteria. Next, the full text of the remaining
studies was used to select additional studies from the reference lists. Studies on the dietary association
of nutrition had to use (semiquantitative) food frequency questionnaires, and/or a detailed interview in
case of vitamin supplements use, and had to use clear criteria for defining the type of glaucoma for final
inclusion if applicable. The most common forms of glaucoma: primary open-angle glaucoma (POAG),
primary angle-closure glaucoma (PACG), normal-tension glaucoma (NTG), and pseudoexfoliation
(PEX) glaucoma were considered eligible. Other causes of glaucoma were excluded.
2.2. Data Extraction and Quality Assessment
The studies were described according to a method described elsewhere [11]. For each study we
extracted the names of authors, title, year of publication, study design, sample size, definition of type
of glaucoma, effect estimates, exposure assessment method, and confounders. Next, to assess the
methodological quality within individual studies the Newcastle-Ottawa Scale (NOS) for assessing the
quality of comparative nonrandomized studies was used for the retrieved studies [12]. Studies were
classified according to different vitamins: A, B-complex, C, D, and E.
Per nutrient we firstly describe the possible mechanism regarding to its possible influence in
glaucoma. Secondly, we provide an overview of studies that investigated the nutrient in question in
relation to blood or aqueous humour levels in patients with glaucoma. Thirdly, we provide an overview
of the studies that investigated the association of intake of the nutrient in question with glaucoma.
Finally, we summarize the evidence from the literature on the association of both blood levels and
dietary intake of vitamins, with glaucoma. For this purpose all investigators (WDR, JSAGS, and CABW)
independently judged/scored whether a vitamin was not (0), possibly (1), probably (2), or definitely (3)
associated with glaucoma. They were blinded for the study that assessed the association of the vitamin
with glaucoma. When assessing the evidence for an association, they were given the following data:
the number of studies that tested an association, the sample size of the studies, the prevalence of
glaucoma in the studies, the quality of the studies, and whether there was a (statistically significant)
difference. Next, a final score per nutrient was presented per vitamin.
2.3. Data Synthesis and Analysis
Results of retrieved studies are presented as Hazard Ratio (HR) or Odds Ratio (OR) with
corresponding 95% confidence interval (CI) if provided. Meta-analyses were performed to calculate
the summary effect estimate of the relation between the vitamin and glaucoma.
If for a specific nutrient multiple studies presented their effect size on glaucoma, a meta-analysis
using fixed- or random-effects models was performed to calculate the combined effect through the
Nutrients 2018, 10, 359 3 of 14
different studies for the association of the specific nutrient with glaucoma. Heterogeneity of the
meta-analyses was measured by calculating the I2 [13]. In case of homogeneity (or low heterogeneity)
the fixed effects model was used. If heterogeneity was substantial (I2 > 50%) the random effects model
was used. If heterogeneity still remained high (I2 > 50%), the study that created the heterogeneity was
excluded. This was done by sequentially omitting one study and reanalyzing the pooled estimate for
the remaining studies [14]. The study that caused the heterogeneity was compared in detail to the
other studies to find differences that could explain the heterogeneity.
A few articles used a different measure of effect size (HR). It has been suggested that these may
not be pooled in a meta-analysis with OR’s [15] (Cochrane website). However, in cohort studies with a
low disease prevalence or incidence (<20%) in the study population the OR is close to the risk ratio,
which can be combined with HR’s in a pooled meta-analysis [16] (Cochrane website).
Statistical analyses were performed using RevMan version 5.3 for Mac (Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2014) and R statistical package version 2.11.1 for Mac
(www.r-project.org).
3. Results
The literature search yielded a total of 384 articles from PubMed and 275 from the Embase
database. After exclusion of those without an available abstract, 265 and 235 articles remained,
respectively. Screening of the reference lists of included articles yielded one additional study.
Finally, a total of 36 articles were included of which five were eligible for a meta-analysis (Figure 1;
Supplementary Table S1). Regarding the quality rating of each of the included studies, the mean
total quality score for all studies was 6.8 (interquartile range: 6 to 8), on a scale from 0 to 9
(Supplementary Table S2). Table 1 presents an overview of the investigated vitamins retrieved from
the search results: vitamins A, B1, B2, B3, B6, B9, B12, C, D, and E, with their corresponding properties
and food sources. Several studies assessed the association of blood levels of vitamins with several
forms of glaucoma (Supplementary Table S3).
Vitamin A is known for its function in the retina. Five studies reported on the association of
blood levels of vitamin A and glaucoma. One study reported higher vitamin A levels in patients
with POAG compared to NTG [17] and one also to controls [18]. Three other studies could not find a
significant difference [19–21]. In contrast, regarding to dietary intake of retinol equivalents two large
studies reported a protective effect on OAG [1,22]. A borderline significant association was found in
the Study on osteoporotic fractures in women [23]. However, the Nurses’ Health Study and Health
Professionals Follow-up Study and NHANES did not find a significant association between vitamin A
and self-reported POAG [21,24].
Vitamin B-complex-investigated vitamins are B1, B2, B3, B6, B9, and B12. Nineteen studies
reported on the association of blood levels of vitamin B-complex and glaucoma. Of these, there was one
on vitamin B1, none on vitamin B2 or B3, three on B6, eight on B9, and seven on B12. Patients with OAG
have significant lower serum levels of vitamin B1 and B12 compared to controls in two studies [25,26].
Others reported no significant differences in plasma levels of vitamin B6 or serum levels of B9 or
B12 in patients with OAG compared to controls [17,20,27–30]. However, lower vitamin B9 and B12
are strongly related to higher homocysteine. Homocysteine generates oxidative stress and induces
apoptosis in retinal ganglion cells. Increased levels of homocysteine in aqueous humour and plasma
in patients with POAG were reported [29]. A relation between homocysteine and IOP or NTG was not
found [31,32]. For PEX glaucoma results are slightly different. A meta-analysis revealed that patients
with PEX have a high prevalence of hyperhomocysteinemia [33]. Decreased levels of vitamin B6, B9 and
B12 were found to be associated with elevated homocysteine levels in patients with PEX glaucoma [34].
One study that compared the levels of vitamin B6, B9 and B12 reported higher plasma levels of
vitamin B6 in NTG and POAG patients, but no significant difference in serum levels of vitamin B9
and B12 between the groups [35]. The latter finding was in line with earlier studies [19,27]. Studies on
dietary intake of vitamin B-complex and glaucoma did not reveal univocal results. For vitamin B1
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the Rotterdam Study reported a protective effect on OAG, though the Study on osteoporotic fractures
did not find any association between vitamin B1 and OAG [1,22,23]. The latter study also reported
an association of vitamin B2 with OAG (OR [95% CI]: 0.39 [0.17–0.86]). For the association of dietary
intake of vitamin B3, B6 or B9 with OAG no association was found [22,23]. Vitamin B9 intake may
lower the risk of PEX probably by reducing homocysteine levels [36]. Concerning dietary intake of
vitamin B12 none of the retrieved studies reported an association with OAG. One study reported no
association of vitamin B12 intake with PEX glaucoma [36]. An interesting finding is that patients with
vitamin B12 deficiency have a thinner retinal nerve fiber layer compared to controls. This thinning was
correlated with plasma vitamin B12 levels [37].
Vitamin C is an essential nutrient involved in the repair of tissue. Four studies reported on the
association of blood levels of vitamin C and glaucoma. In patients with NTG lower serum levels of
vitamin C compared to controls have been reported [19], but for OAG results are conflicting [21,25,38].
In aqueous humour one study measured higher levels of vitamin C in OAG compared to controls [39],
but two studies reported the opposite [40,41]. Oral vitamin C may increase its concentration in the
aqueous humour [42]. Concerning the dietary intake of vitamin C results on the risk of glaucoma
are contradicting. Two studies found a significant protective effect of vitamin C on OAG [21,22].
However, others did not find an association between vitamin C and POAG [1,23,24]. An important
source of vitamin C is green leafy vegetables. Several studies provided evidence for an association
of these foods with glaucoma (OR [95% CI]: 0.82 [0.69–0.97]; P-trend = 0.02) [43,44]. This is in line
with the protective association with glaucoma for green collards and leaf cabbage found in two other
studies (OR [95% CI]: 0.31 [0.11–0.91] and 0.43 [0.21–0.85], respectively) [22,23].
Vitamin D is important for certain minerals (e.g., Calcium). Five studies reported on the
association of blood levels of vitamin D and glaucoma. In one study patients with glaucoma were
reported to have lower serum 25-hydroxyvitamin D levels (OR [95% CI]: 0.89 [0.80–0.99]) and higher
prevalence of vitamin D deficiency (OR [95% CI]: 2.09 [1.06–4.12]) compared to controls [45]. This is
in agreement with the Korean National Health and Nutrition Examination Survey (KNHANES).
They found a vertically reversed J-shaped association of serum 25-hydroxyvitamin D with OAG
(OR [95% CI]: 1.61 [1.09–2.38] for the lowest quintile compared to the second highest quintile;
P-trend [quadratic] = 0.02), with a more pronounced effect in males [46]. Similarly, two other studies
showed lower serum 25-hydroxyvitamin D levels in POAG patients [47,48]. In contrast, the retrospective
cross-sectional Kangbuk Samsung health study did not find any difference in total vitamin D levels between
patients with and without glaucoma [49]. Also a nested case-control study revealed no associations of
25-hydroxyvitamin D levels with IOP [50]. Vitamin D-related metabolites and polymorphisms of the
vitamin D receptor gene have been negatively associated with POAG [47,51]. Regarding the dietary
intake of vitamin D results on the risk of glaucoma are less promising. Only few studies assessed this
relation. The Study on osteoporotic fractures in African-Americans found no association of vitamin D
with glaucoma (OR [95% CI]: 0.91 [0.45–1.83]) [22].
Vitamin E is seen as an important antioxidant. Six studies reported on the association of blood
levels of vitamin E and glaucoma. One reported lower plasma levels of vitamin E in the POAG
group [38]. One study reported no association [21], and two other studies found increased serum
vitamin E levels in glaucoma patients [17,18]. For NTG, one study showed lower plasma levels of
vitamin E in NTG patients [20], while other studies found no difference in plasma levels of vitamin
E between patients with NTG and controls [19,21,52]. Concerning aqueous humour, lower levels of
vitamin E have been reported in patients with POAG and PACG [41]. Studies on the dietary intake of
vitamin E and its association with OAG revealed no significant associations [1,21–24].
The directions of the effect size between results of blood levels of vitamins on glaucoma, and of dietary
intake of vitamins on glaucoma are not always in agreement with each other (Supplementary Tables S4 and
S5 for OAG). This either suggests a poor association of vitamins with glaucoma or a poor correlation
between blood levels of vitamins and intake of vitamins. In case of the former a meta-regression
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analysis would be helpful, however, due to low number of studies we did not perform an analysis as
such. In case of the latter, a meta-analysis would be meaningful.
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Table 1. Overview of investigated vitamins retrieved from the systematic review.
Vitamin Vitamer Chemical Name Remarks Relevance to the Eye Main Sources Rich Food Sources
A Retinol (A1) Preformed retinols (or active form)—isimmediately available to the body
Important for rhodopsin found in the retina for visual
phototransduction, and protects against free radicals i.e.,
acts as an antioxidant
Animal products Liver, eggs, cheese, butter, dark greenvegetables (spinach) and carrots
Precursors (or provitamins)—has to be
metabolized into an active form
Important for rhodopsin found in the retina for visual
phototransduction, and protects against free radicals i.e.,
acts as an antioxidant
Plant products Vegetables and fruits with orangepigments (known as carotenoids)
B-complex Thiamin (B1) Some flavonoids may antagonize vitamin B1
Serve as coenzymes in catabolism of amino acids,
carboxylase, cell division and growth, and DNA synthesis
and repair in every cell of the body
Animal/plant products
Yeast extract, cereal grains (especially in
the outer layer of the grain and in the
germ), meat (pork), nuts, peas, and beans
Riboflavin (B2) Primary coenzyme form of vitamin B6
Used in the treatment of corneal ectasia for strengthening
of corneal collagen tissue. It can also be used as a
prophylaxis for migraine: a potential risk factor
for glaucoma
Animal/plant products Milk, cheese, eggs, green leafy vegetables,almonds, and mushrooms
Niacin (B3) May be converted to nicotinamide, which isanother form of vitamin B3
Involved in vasodilatation of among others retinal
arterioles. It improves endothelial dysfunction Animal/plant products Fish, dates, nuts, and cereal grains
Pyridoxin (B6) Dietary vitamin B6 cannot be used withoutvitamin B2 (Riboflavin)
Involved in neurotransmitter synthesis. Plays a role in the
treatment of gyrate atrophy of the choroid and retina Animal/plant products
Meat (pork), bananas, chickpeas, potatoes,
and pistachios
Folate (B9) Synthetic form, used in supplements andfood processing, is called Folic acid
When combined with vitamin B12 it reduces
homocysteine levels, which induces vascular injury,
alterations in extracellular matrix remodeling, and
neuronal cell death
Plant products
Cereal grains (especially in the outer layer
of the grain and in the germ), dark green
leafy vegetables, nuts, peas, and beans
Cobalamin (B12) Should be in balance with folic acid and iron
Coenzyme involved in the metabolism of every cell of the
body. Deficiency can results in elevated homocysteine
levels, optic neuropathy, and irreversible damage to
nervous system
Animal products Fish, red meat, eggs, and cheese
C Ascorbic acid
Oxidized form of vitamin C is reduced by
glutathione, which helps maintain vitamin C
in a reduced (active) form
Enzymatic cofactor for collagen synthesis and very
effective in scavenging of reactive oxygen species, i.e.,
vitamin C is an important non-enzymatic antioxidant
Plant products
Peppers, green leafy vegetables, and in
many fruits (kiwis, strawberries, oranges,
guavas, and papaya)
D Cholecalciferol
Most important subtype in humans is
vitamin D3. In the liver vitamin D is
converted to 25-hydroxyvitamin D, which is
used as a biomarker
Responsible for intestinal absorption of several minerals
including calcium, iron, magnesium, and zinc Sunlight exposure Mushrooms, cod liver oil, fish, and cereals
E Tocopherol Excessive vitamin E may lead to vitamin K *deficiency resulting in bleedings
Plays a role in the oxidation of low-density lipoproteins
(LDL) and prevents the production of damaging free
radicals. Therefore vitamin E is seen as an important
antioxidant. Deficiency might result in peripheral
neuropathy and retinopathy
Plant products
Nuts (especially almonds), sunflower oil
and seeds, avocados, and dark green
leafy vegetables
* = None of the retrieved studies assessed the relation between vitamin K and glaucoma.
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Figure 2 displays the results of the meta-analysis. As only two studies reported an effect size
for vitamin B2 and B3, and only one study reported an effect size for vitamin D on glaucoma,
no meta-analysis was performed for these vitamins. A total of five eligible studies were included
in the meta-analysis that assessed the dietary intake of vitamins and its association with OAG
(Table 2). The prevalence of OAG in the study populations were in the range of 0.41–13.18% totaling
940 OAG cases and 123,697 controls. Therefore, the ORs of the studies could be interpreted as
risk ratios. Dietary intake of vitamin A had a pooled OR [95% CI] of 0.58 [0.37–0.91] on OAG.
However, the heterogeneity was high (I2 = 51%). After omitting the study that contributed to
the heterogeneity, the pooled OR [95% CI] was 0.45 [0.30–0.68]; I2 = 0%). For vitamin B1, C and
E no significant association with OAG was found (OR [95% CI]: 0.84 [0.47–1.51]; 0.68 [0.38–1.22];
0.95 [0.75–1.19]; respectively). However, the meta-analysis for vitamin C showed high heterogeneity
(I2 = 72%). After omitting the studies that significantly contributed to the heterogeneity, the pooled
OR [95% confidence interval] was 0.39 [0.23–0.67] with no heterogeneity (I2 = 0%). Regarding green
leafy vegetables a source for vitamin A, C and nitrate, a joint OR [95% CI] of 0.55 [0.30–1.02] was found
with high heterogeneity (I2 = 67%). Again the study that contributed to the high heterogeneity was
the Nurses’ Health Study and Health Professionals Follow-up Study [44]. Deleting this study from
the random-effects model resulted in a joint OR [95% CI] of 0.39 [0.22–0.70] with no heterogeneity
(I2 = 0%). Although this effect was based on only two studies, all three studies showed a significant
protective association with OAG.
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Figure 2. Meta-analyses for the association of vitamin A (I), B1 (II), C (III), and E (IV) with open-angle
glaucoma. Black diamonds indicate the overall OR. The size of the red box is inversely proportional to
the variance. Horizontal lines indicate 95% CI. The dashed vertical line in each panel shows the value
for no effect (OR = 1.0).
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Table 2. Characteristics of the included studies for the meta-analyses.
Study Study Design Age (Years) Race N (Patients) Prevalence (%) Definition of Glaucoma Adjusted Covariates
Glaucoma
(Undefined) OAG N (Total) Cases/Total
Coleman 2008 [23] cross-sectional cohort >65 Caucasian/African 95 1155 8.23 Based on ONH photographsand VF
Study sites, age, race and ethnicity, education,
smoking, alcohol, walking for exercise, BMI,
self-rated health status, self-reported diabetes,
self-reported hypertension, and age-related
macular degeneration.
Giaconi 2012 [22] cross-sectional case-control >65 African 77 584 13.18 Based on ONH photographsand VF
Study sites, age, education, smoking, alcohol,
walking for exercise, BMI, self-rated health
status, self-reported diabetes, and
self-reported hypertension.
Kang 2003 [24] prospective cohort >40 Caucasian/African 474 116,484 0.41
Self-reported glaucoma,
confirmed with
medical records
African heritage, diabetes, hypertension, BMI,
physical activity, alcohol intake, and smoking.
Ramdas 2012 [1] prospective cohort ≥55 Caucasian 91 3502 2.60
Based on slitlamp, ONH
(photographs and scans),
and VF
Age, gender, IOP, IOP-lowering treatment,
BMI, beta-carotene, vitamin B1, B12, E,
and magnesium.
Wang 2013 [21] cross-sectional cohort ≥40 Multiracial 203 2912 6.97 Self-reported glaucoma
Age, demographic variables, smoking,
alcohol, self-reported general health condition,
and self-reported diabetic retinopathy.
OAG = open-angle glaucoma; VF = Visual field; ONH = Optic nerve head appearance; IOP = Intraocular pressure; BMI = Body mass index.
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If we combine the studies on the association of blood levels of vitamins with OAG, and the
studies on the association of dietary intake of vitamins with OAG, results are not very different.
Supplementary Table S6 shows the level of evidence from the literature for the association of blood
levels of vitamins and vitamin intake with OAG (following Supplementary Table S5). Of all vitamins
vitamin A and C probably have a protective effect on OAG, and vitamin B1 is possibly associated
with OAG.
4. Discussion
This review summarizes findings in the literature concerning the association of vitamins
with glaucoma. Most of the studies focused on POAG. An important finding was the probable
protective effect of vitamin A intake on OAG. The association of vitamin C with OAG did not reach
statistical significance in the current meta-analysis unless heterogeneity was taken into account.
Furthermore, dark green leafy vegetables, which contain vitamin A, C and nitrate, seem to have
a beneficial effect in glaucoma. However, it is possible that nitrate is responsible for this effect.
No consistent association was found for plasma or serum levels of any of the vitamins with glaucoma
(Supplementary Tables S3 and S4). When combining studies on blood levels of vitamins with studies
on dietary intake of vitamins, we report a probable association of vitamin A and C with OAG, and a
possible association of vitamin B1 with OAG.
Several studies have implicated vitamins in affecting the course of common eye diseases. Vitamin A,
B9, C, and E are well-known antioxidants and may prevent age-related eye disorders such as cataract
and age-related macular degeneration [53,54]. It has been reported that administration of nicotinamide,
a form of vitamin B3 (Table 1), has a strong neuroprotective effect in glaucoma independent of IOP [55].
Although studies on the dietary intake of vitamin B3 did not find an association with OAG [22,23],
it should be noted that vitamins may indirectly influence other important parameters for OAG.
For example, vitamin E has vasoregulatory effects via protein kinase C [56], which is, together with
Rho/ROCK system activation, believed to be the main factor inducing aqueous humour outflow by
trabecular meshwork cell relaxation in OAG [57]. According to the current literature it is likely that
oxidative stress also plays a role in the pathogenesis of glaucoma. Systemic oxidative stress is associated
with decreased ocular blood flow [58]. This association is related to the vascular permeability and
results in a release of endothelin and nitric oxide (both oxidants). Blood levels of endothelin-1 have
found to be significantly higher in patients with POAG [20]. The association of nitric oxide with
glaucoma has been reported before [59]. Thus the nitrate-nitrite-nitric oxide pathway may play an
important role in POAG. Nitrate is a source of nitric oxide and available in dark green leafy vegetables.
In addition to nitrate, dark green leafy vegetables are also rich in vitamin A, C, and K. The present
review suggested a beneficial association of vitamin A and C with OAG, but studies on vitamin K
vs. OAG are currently lacking. Thus dark green leafy vegetables contain several relevant nutrients
for OAG. This is emphasized by the fact that all retrieved studies on the association of green leafy
vegetables with OAG found a significant association [22,23,43,44]. Another benefit patients with
glaucoma may have from vitamin A is that vitamin A protects the conjunctiva and relieves dry eye
symptoms caused by long-term application of IOP-lowering eye drops [60].
At present, there is no strong evidence to support a hypothesis that blood levels of vitamins
impact glaucoma. An explanation could be the correlation between blood levels of vitamins and
intake of vitamins, which depends on many co-factors. To mention a few: incorrect reported intake of
vitamins from dietary supplements or food additives, different food processing techniques which may
affect vitamin contents (e.g., exposure to high temperatures may lead to break down of some vitamins),
various lifestyle factors (e.g., smoking, exercise, chronic low-grade inflammation) which may reduce
vitamin levels, biases in the assessment of dietary vitamin intake, or potential influence of genetic
variability on metabolism or absorption of vitamins [61]. For example, the SLC23A2 gene, which plays
a role in the absorption and accumulation of vitamin C in many tissues, has been associated with lower
plasma concentrations of vitamin C and with higher risk of POAG [62]. If the correlation between
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blood levels of vitamins and dietary intake of vitamins is strong then the presented level of evidence
of a possible association of vitamins with glaucoma would be poor. However, a meta-analysis showed
that plasma vitamin C levels and dietary vitamin C intake are only modestly correlated (r = 0.4) [63].
Moreover, subjective judgment of the association of vitamins with OAG was not very different from
the objective meta-analyses when taking studies on blood levels of vitamins into account. It should be
noted that the results of studies on blood levels of vitamins are different between the several forms of
glaucoma (POAG, PACG, NTG, and PEX glaucoma). The assessment of both blood levels and dietary
intake is not standardized, which may contribute to the lack of correlation between blood levels and
dietary intake. Especially the evaluation of vitamin D in this respect is difficult due to its endogenous
synthesis, which could be why few studies have looked at vitamin D.
The quality of the studies was relatively high, but some concerns could be raised. The way patients
were diagnosed with OAG differed between the included studies in the meta-analysis, and therefore
some diagnostic bias might be present. Most studies based their OAG definition on a combination
of optic nerve head abnormalities and glaucomatous visual field loss, but two studies classified
their cases according to self-reports (Table 2). The self-reports were verified by checking the medical
records and to further minimize misclassification participants had to have eye examinations in the
past 2 years [24]. However, as mentioned in the Introduction, from population-based studies we know
that half of the glaucoma cases are undiagnosed [64]. Furthermore, the prevalence of glaucoma was
only 0.41% (Table 2), which is far lower than expected in their age group. This may have lead to an
underestimation of their effect size. The sample size of their study resulted in a high weight in the
current meta-analyses. Taken together this may have induced the heterogeneity, though omitting
this study from the meta-analysis of vitamin A did not affect the results significantly. Cross-sectional
studies are susceptible to bias because one cannot make clear determinations of cause and effect and
often in secondary analyses of meta-analyses, those are separated analyzed, however, omitting these
studies did not affect the results (data not shown).
Another drawback may be the different analyses for the nutrients. Nutrients were analyzed as
tertiles [1], quartiles [21–23], or quintiles [24]. Therefore in the current study only the result of the
highest intake was compared to the lowest intake of that nutrient, which served as the reference in all
studies. Wang, et al. assessed the intake of supplements of vitamin A [21]. The amount of intake of
their first quartile was comparable with the highest intake of the other studies. Including the results of
this first quartile (OR [95% CI]: 0.55 [0.20–1.49] instead of 0.48 [0.13–1.82]) did not alter the results of
the meta-analysis of vitamin A (data not shown).
Another limitation might be publication bias. To address this issue we performed a search in the
abstract itinerary/meeting archives of the two largest congresses in ophthalmology: the Association
for Research in Vision and Ophthalmology (ARVO) and the American Academy of Ophthalmology
(AAO) annual meetings. The same search term of the current study was used and titles of abstract were
screened from the meetings from 2010 to 2016. None of the retrieved abstracts showed contradictive
results, however most studies focused on blood levels of vitamins (data not shown).
In conclusion, although there is sufficient evidence that oxidative stress plays an important role in
the pathogenesis of different types of glaucoma, studies on the blood levels of vitamins in patients with
glaucoma are inconclusive and do not correlate with results on the effect of dietary intake of vitamins
on glaucoma. Moreover, studies on the association of the dietary intake of vitamins with glaucoma are
scarce. However, vitamin A intake probably has a protective effect on glaucoma. Vitamin C may have
a comparable effect on glaucoma as well. This review highlighted new targets and strategies for future
research aiming to assess the influence of nutrition on glaucoma. Especially, randomized clinical trials
are required to verify the role of these vitamins in glaucoma and to investigate whether nutritional
supplements can become part of the treatment of glaucoma. Although a nutritional supplement for
glaucoma might be an additional option to treat persons with advanced glaucoma, a clear effect on the
disease as seen in age-related macular degeneration probably does not exist.
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